| Budget Amount *help |
¥18,200,000 (Direct Cost: ¥14,000,000、Indirect Cost: ¥4,200,000)
Fiscal Year 2015: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2014: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2013: ¥6,760,000 (Direct Cost: ¥5,200,000、Indirect Cost: ¥1,560,000)
|
|---|
| Outline of Final Research Achievements |
The epidemiological study of Leishmaniasis was L. major only using lesion of several different parts of patients and major vector was S. Africana in the Volta region. In the genetic analysis of drug-resistant malaria, most of the patient samples collected after 2010 showed a drug-sensitive gene type and one of reason of the result was caused by Ghana government malaria treatment-polish was changed to Artemisinin-based combination therapy than other classical malaria drugs.To effective analysis of HCV patient in Ghana, the universal primer-set was determined in the 5'-untranslated region of HCV genome.
We found a new drug discovery seeds showing the ability to inhibit both of malaria and leishmaniasis using in Milletia Thonningii of Ghanaian natural products.
|
